Tags
Supplies of ZMapp, which is seen as the most promising experimental treatment for Ebola, are expected to be limited to hundreds or thousands of treatment courses by early 2015.
from NYT > Business Day http://ift.tt/1psZd4N
via IFTTThttp://ift.tt/eA8V8J http://ift.tt/IP98QF
Advertisements